604 related articles for article (PubMed ID: 15111862)
1. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
Laredo J; Xue L; Husak VA; Ellinger J; Singh G; Zamora PO; Greisler HP
J Vasc Surg; 2004 May; 39(5):1059-65. PubMed ID: 15111862
[TBL] [Abstract][Full Text] [Related]
2. Silyl-heparin adsorption improves the in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
Laredo J; Xue L; Husak VA; Ellinger J; Greisler HP
Am J Surg; 2003 Nov; 186(5):556-60. PubMed ID: 14599625
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model.
Lin PH; Bush RL; Yao Q; Lumsden AB; Chen C
J Surg Res; 2004 May; 118(1):45-52. PubMed ID: 15093716
[TBL] [Abstract][Full Text] [Related]
4. Sustained Thromboresistant Bioactivity with Reduced Intimal Hyperplasia of Heparin-Bonded Polytetrafluoroethylene Propaten Graft in a Chronic Canine Femoral Artery Bypass Model.
Freeman J; Chen A; Weinberg RJ; Okada T; Chen C; Lin PH
Ann Vasc Surg; 2018 May; 49():295-303. PubMed ID: 29197605
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model.
Cagiannos C; Abul-Khoudoud OR; DeRijk W; Shell DH; Jennings LK; Tolley EA; Handorf CR; Fabian TC
J Vasc Surg; 2005 Nov; 42(5):980-8. PubMed ID: 16275457
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
Lumsden AB; Morrissey NJ;
J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
[TBL] [Abstract][Full Text] [Related]
7. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
[TBL] [Abstract][Full Text] [Related]
8. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR
J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575
[TBL] [Abstract][Full Text] [Related]
9. A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans.
Heyligers JM; Lisman T; Verhagen HJ; Weeterings C; de Groot PG; Moll FL
J Vasc Surg; 2008 Feb; 47(2):324-9; discussion 329. PubMed ID: 18241756
[TBL] [Abstract][Full Text] [Related]
10. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency.
Ishii Y; Sakamoto S; Kronengold RT; Virmani R; Rivera EA; Goldman SM; Prechtel EJ; Hill JG; Damiano RJ
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1237-45; discussion 1245-6. PubMed ID: 18544361
[TBL] [Abstract][Full Text] [Related]
11. Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts.
Heyligers JM; Verhagen HJ; Rotmans JI; Weeterings C; de Groot PG; Moll FL; Lisman T
J Vasc Surg; 2006 Mar; 43(3):587-91. PubMed ID: 16520178
[TBL] [Abstract][Full Text] [Related]
12. Improvements in GORE-TEX vascular graft performance by Carmeda BioActive surface heparin immobilization.
Begovac PC; Thomson RC; Fisher JL; Hughson A; Gällhagen A
Eur J Vasc Endovasc Surg; 2003 May; 25(5):432-7. PubMed ID: 12713782
[TBL] [Abstract][Full Text] [Related]
13. The effect of carbon coating and porosity on early patency of expanded polytetrafluoroethylene grafts: an experimental study.
Akers DL; Du YH; Kempczinski RF
J Vasc Surg; 1993 Jul; 18(1):10-5. PubMed ID: 8326650
[TBL] [Abstract][Full Text] [Related]
14. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results.
Daenens K; Schepers S; Fourneau I; Houthoofd S; Nevelsteen A
J Vasc Surg; 2009 May; 49(5):1210-6. PubMed ID: 19394550
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access.
Shemesh D; Goldin I; Hijazi J; Zaghal I; Berelowitz D; Verstandig A; Olsha O
J Vasc Surg; 2015 Jul; 62(1):115-22. PubMed ID: 25770987
[TBL] [Abstract][Full Text] [Related]
16. Thrombogenicity of a fibronectin-coated, experimental polytetrafluoroethylene graft.
Kempczinski RF; Ramalanjaona GR; Douville C; Silberstein EB
Surgery; 1987 Apr; 101(4):439-44. PubMed ID: 3563890
[TBL] [Abstract][Full Text] [Related]
17. Transgraft infusion of heparin to prevent early thrombosis of expanded PTFE grafts in canine femoral veins.
Chen C; Hughes JD; Mattar SG; Hanson SR; Lumsden AB
Ann Vasc Surg; 1996 Mar; 10(2):147-55. PubMed ID: 8733867
[TBL] [Abstract][Full Text] [Related]
18. Prevention of neointimal hyperplasia associated with modified stretch expanded polytetrafluoroethylene hemodialysis grafts (Gore) in an experimental preclinical study in swine.
Gessaroli M; Bombardi C; Giunti M; Bacci ML
J Vasc Surg; 2012 Jan; 55(1):192-202. PubMed ID: 21944911
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of ibuprofen treatment on thrombogenicity of expanded polytetrafluoroethylene vascular grafts.
Gloviczki P; Hollier LH; Dewanjee MK; Trastek VF; Kopesky KR; Kaye MP
Surgery; 1984 Feb; 95(2):160-8. PubMed ID: 6695334
[TBL] [Abstract][Full Text] [Related]
20. Improvement of patency rate in heparin-coated small synthetic vascular grafts.
Walpoth BH; Rogulenko R; Tikhvinskaia E; Gogolewski S; Schaffner T; Hess OM; Althaus U
Circulation; 1998 Nov; 98(19 Suppl):II319-23; discussion II324. PubMed ID: 9852921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
